Nath Bio-Genes (India) Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

19.00

19.00

19.00

19.00

19.00

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

554.35

522.97

594.27

538.61

488.58

Loan funds

Secured loans

105.21

92.96

95.02

69.80

57.70

Unsecured loans

-

-

-

-

-

Total

678.57

634.93

708.30

627.42

565.28

Uses of funds

Fixed assets

Gross block

264.01

263.29

264.89

264.10

249.46

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

19.64

18.40

17.96

18.07

17.74

Net block

244.38

244.89

246.93

246.03

231.72

Capital work-in-progress

-

-

-

-

-

Investments

5.06

5.06

5.05

5.00

5.00

Net current assets

Current assets, loans & advances

543.53

491.96

537.54

478.92

409.35

Less : current liabilities & provisions

114.41

106.98

81.21

102.52

80.79

Total net current assets

429.13

384.98

456.33

376.40

328.56

Miscellaneous expenses not written

-

-

-

-

-

Total

678.57

634.93

708.30

627.42

565.28

Notes:

Book value of unquoted investments

5.06

5.06

5.05

5.00

5.00

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

79.10

68.30

62.41

47.00

45.17

Number of equity sharesoutstanding (Lacs)

190.04

190.04

190.04

190.04

190.04